[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0015490A - Combinações oncolìticas para o tratamento de câncer - Google Patents

Combinações oncolìticas para o tratamento de câncer

Info

Publication number
BR0015490A
BR0015490A BR0015490-3A BR0015490A BR0015490A BR 0015490 A BR0015490 A BR 0015490A BR 0015490 A BR0015490 A BR 0015490A BR 0015490 A BR0015490 A BR 0015490A
Authority
BR
Brazil
Prior art keywords
cancer
treatment
combinations
oncolytic
oncolytic combinations
Prior art date
Application number
BR0015490-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C R Smith
William Thomas Mcmillen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR0015490A publication Critical patent/BR0015490A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
BR0015490-3A 1999-11-11 2000-11-09 Combinações oncolìticas para o tratamento de câncer BR0015490A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
BR0015490A true BR0015490A (pt) 2002-07-09

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015490-3A BR0015490A (pt) 1999-11-11 2000-11-09 Combinações oncolìticas para o tratamento de câncer

Country Status (22)

Country Link
EP (1) EP1231938A2 (zh)
JP (1) JP2003513916A (zh)
KR (1) KR20020069512A (zh)
CN (1) CN1390139A (zh)
AR (1) AR032432A1 (zh)
AU (1) AU778829B2 (zh)
BR (1) BR0015490A (zh)
CA (1) CA2391416A1 (zh)
CZ (1) CZ20021551A3 (zh)
EA (1) EA200200545A1 (zh)
HK (1) HK1050132A1 (zh)
HU (1) HUP0204449A3 (zh)
IL (1) IL148579A0 (zh)
MX (1) MXPA02004733A (zh)
NO (1) NO20022245L (zh)
NZ (1) NZ517667A (zh)
PE (1) PE20010701A1 (zh)
PL (1) PL355172A1 (zh)
SK (1) SK6492002A3 (zh)
TR (1) TR200201245T2 (zh)
WO (1) WO2001034137A2 (zh)
ZA (1) ZA200202822B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
KR20030019372A (ko) * 2000-05-09 2003-03-06 크레이톤 유니버시티 암세포의 증식 억제 및 세포사멸 유도 방법
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
EP2298742B1 (en) 2005-06-30 2014-01-08 High Point Pharmaceuticals, LLC phenoxy acetic acids as PPAR delta activators
EP2386540A1 (en) 2005-12-22 2011-11-16 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
JP5207972B2 (ja) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 カルボン酸誘導体
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
BR112015009751A2 (pt) 2012-10-31 2017-07-11 Bayer Cropscience Ag novos compostos heterocíclicos como pesticidas
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
ZA200202822B (en) 2003-09-23
CZ20021551A3 (cs) 2003-02-12
HK1050132A1 (zh) 2003-06-13
TR200201245T2 (tr) 2004-08-23
JP2003513916A (ja) 2003-04-15
CN1390139A (zh) 2003-01-08
IL148579A0 (en) 2002-09-12
NO20022245L (no) 2002-07-09
PE20010701A1 (es) 2001-07-07
EA200200545A1 (ru) 2002-12-26
AR032432A1 (es) 2003-11-12
AU778829B2 (en) 2004-12-23
AU1599001A (en) 2001-06-06
WO2001034137A3 (en) 2002-02-14
CA2391416A1 (en) 2001-05-17
HUP0204449A2 (hu) 2003-04-28
MXPA02004733A (es) 2002-08-30
NZ517667A (en) 2004-05-28
PL355172A1 (en) 2004-04-05
WO2001034137A2 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
NO20022245D0 (no) 2002-05-10
KR20020069512A (ko) 2002-09-04
SK6492002A3 (en) 2003-09-11
HUP0204449A3 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
BR0015490A (pt) Combinações oncolìticas para o tratamento de câncer
MA26782A1 (fr) Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.
PT1193270E (pt) Pirrolobenzodiazepinas
ID27265A (id) Popok sekali pakai
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE60213276D1 (de) 1,2,4-thiadiazoliumverbindungen als melanocortinrezeptor-modulatoren
ID27095A (id) Popok sekali pakai
ID28132A (id) Popok sekali pakai
NO992102D0 (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
BR0013417B1 (pt) composiÇço aquosa.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
BR0109542A (pt) Derivados de imidazopirina alquilados
ID28504A (id) Popok sekali pakai
ID26456A (id) Popok sekali pakai
IT1311921B1 (it) Composti farmaceutici.
BR0007922A (pt) Compostos calcilìticos
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
BR0017046A (pt) Uso de azóis para prevenção de câncer de pele
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
NO20021718L (no) Substituerte pyrroler som antiproliferative midler for behandling av kreft

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8 ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.